Loading...

Ledrondn (Zoledronic Acid) 4 mg/vial

18,00


Ledrondn contains zoledronic acid 4 mg — a medication from the bisphosphonate group used for the treatment and prevention of bone tissue disorders. It is used in patients with bone metastases associated with cancer, as well as for the treatment of tumor-induced hypercalcemia. The medicine is administered intravenously as an infusion after reconstitution of the lyophilized powder.

SKU: LED-4MG-V1 Categories: , Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Description

Ledrondn (Zoledronic Acid) 4 mg/vial

Ledrondn is a medicinal product based on zoledronic acid, belonging to the group of bisphosphonates. The medicine is used for the treatment and prevention of bone tissue disorders, particularly in patients with oncological diseases. It helps reduce bone destruction, lowers calcium levels in the blood, and helps prevent fractures and other complications associated with bone damage.

The medicine is administered intravenously as an infusion after reconstitution of the lyophilized powder.


Composition

Active substance:

Zoledronic Acid — 4 mg per vial.


Dosage form

Lyophilized powder for preparation of a solution for intravenous infusion in a vial.


Pharmacological action

Zoledronic acid belongs to third-generation bisphosphonates. It inhibits the activity of osteoclast cells responsible for bone tissue destruction. This helps to:

  • reduce bone resorption

  • increase bone strength

  • reduce the risk of fractures

  • decrease calcium levels in the blood in tumor-related conditions.


Indications for use

The medicine is used for:

  • treatment of tumor-induced hypercalcemia

  • prevention of bone complications in cancer patients

  • treatment of bone metastases

  • treatment of multiple myeloma

  • treatment and prevention of osteoporosis

  • treatment of Paget’s disease of bone.


Method of administration

The medicine is administered only intravenously as an infusion.
The dosage and treatment regimen are determined by a physician depending on the disease and the patient’s condition.


Possible side effects

Possible reactions may include:

  • fever

  • joint and muscle pain

  • weakness or fatigue

  • nausea

  • headache

In rare cases:

  • impaired kidney function

  • decreased calcium levels in the blood

  • osteonecrosis of the jaw.


Contraindications

  • hypersensitivity to zoledronic acid

  • severe renal impairment

  • pregnancy and breastfeeding.


Storage conditions

Store at a temperature below 25°C in a dry place protected from light.
Keep out of reach of children.


Manufacturer

Biozenta Lifesciences Pvt. Ltd.
India.

Reviews

There are no reviews yet.

Be the first to review “Ledrondn (Zoledronic Acid) 4 mg/vial”

Your email address will not be published. Required fields are marked *

With this people buy…

×
×

Cart